Clinical trial related with transplantation therapy with human autologous cell mixed sheets for refractory cutaneous ulcer - Autologous cell mixed sheets transplantation for refractory cutaneous ulcer

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine0 个研究点目标入组 6 人开始时间: 2018年3月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients suffering from critical limb ischemia. 2. Patients suffering from malignant neoplasm. 3. Patients suffering from bacterial infections such as treponema palladium, chlamydia, gonorrhea and tuberculosis. 4. Patients suffering from infections such as hepatitis B and C viruses, human immunodeficiency virus, human T lymphotropic virus type 1 and parvovirus B19. 5. Patients with allergy of local anesthesia. 6. Hemoglobin: < 8.0 g/dL, Plt: < 50,000 /uL, Prothrombin time: < 40% 7. Patients with sepsis or suspected with. 8. Patients with congenital coagulopathy, antiplatelet drug use, or anticoagulant use. 9. Patients who have experienced other cell or gene therapy 10. Patients who join other clinical trials or joined them within 6 months. 11. Patients with hemodialysis. 12. Patients who developed unstable angina, myocardial ischemia, or cerebral infarction within 3 months 13. Pregnant woman and women who may possibly be pregnant, women in nursing 14. Patients with allergy of aminoglycoside antibiotics. 15. Patient determined to be ineligible for this clinical study by research attending physician.

发起方

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine